Revolutionary Alzheimer's Diagnosis: Embracing a Cancer-like Rating Scale
Alzheimer's disease experts have proposed a new seven-point rating scale for diagnosing patients with the progressive brain disorder. The scale, unveiled at an Alzheimer's Association conference, aims to assess disease progression based on cognitive and biological changes, similar to the staging system used in cancer diagnoses. The new guidelines eliminate terms like mild, moderate, and severe and instead focus on biomarkers and cognitive changes. The revamp was prompted by advancements in detecting Alzheimer's-related proteins and the development of new treatments. The proposed guidelines are open for expert review and comment before being finalized.